APA (7th ed.) Citation

Gong, W., Liu, Y., Seidl, C., Diamandis, E. P., Kiechle, M., Drecoll, E., . . . Dorn, J. (2019). Quantitative assessment and clinical relevance of kallikrein-related peptidase 5 mRNA expression in advanced high-grade serous ovarian cancer. BMC cancer, 19(1), 696-9. https://doi.org/10.1186/s12885-019-5901-0

Chicago Style (17th ed.) Citation

Gong, Weiwei, Yueyang Liu, Christof Seidl, Eleftherios P. Diamandis, Marion Kiechle, Enken Drecoll, Matthias Kotzsch, Viktor Magdolen, and Julia Dorn. "Quantitative Assessment and Clinical Relevance of Kallikrein-related Peptidase 5 MRNA Expression in Advanced High-grade Serous Ovarian Cancer." BMC Cancer 19, no. 1 (2019): 696-9. https://doi.org/10.1186/s12885-019-5901-0.

MLA (9th ed.) Citation

Gong, Weiwei, et al. "Quantitative Assessment and Clinical Relevance of Kallikrein-related Peptidase 5 MRNA Expression in Advanced High-grade Serous Ovarian Cancer." BMC Cancer, vol. 19, no. 1, 2019, pp. 696-9, https://doi.org/10.1186/s12885-019-5901-0.